Healthcare provider profile · identity verified

Harding G Young, MD

Family Practice · LYNWOOD, CA · NPI 1881788669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	544	96
Amlodipine Besylate	Amlodipine Besylate	490	99
Losartan Potassium	Losartan Potassium	390	90
Furosemide	Furosemide	360	67
Potassium Chloride	Potassium Chloride	249	39
Levothyroxine Sodium	Levothyroxine Sodium	219	28
Simvastatin	Simvastatin	212	56
Lisinopril	Lisinopril	211	39
Hydralazine Hcl	Hydralazine Hcl	194	37
Albuterol Sulfate Hfa	Albuterol Sulfate	173	35
Metformin Hcl	Metformin Hcl	164	41
Tamsulosin Hcl	Tamsulosin Hcl	164	28
Atenolol	Atenolol	157	26
Hydrochlorothiazide	Hydrochlorothiazide	145	34
Gabapentin	Gabapentin	143	30
Eliquis	Apixaban	137	19
Carvedilol	Carvedilol	131	39
Memantine Hcl	Memantine Hcl	123	suppressed
Famotidine	Famotidine	120	22
Glipizide	Glipizide	120	24
Omeprazole	Omeprazole	114	23
Benazepril Hcl	Benazepril Hcl	106	29
Donepezil Hcl	Donepezil Hcl	106	suppressed
Clopidogrel	Clopidogrel Bisulfate	104	18
Levetiracetam	Levetiracetam	96	13
Metoprolol Tartrate	Metoprolol Tartrate	94	20
Zolpidem Tartrate	Zolpidem Tartrate	78	12
Felodipine Er	Felodipine	74	18
Allopurinol	Allopurinol	68	18
Finasteride	Finasteride	66	suppressed
Nifedipine Er	Nifedipine	60	19
Lorazepam	Lorazepam	57	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	13
Clonidine Hcl	Clonidine Hcl	54	18
Trazodone Hcl	Trazodone Hcl	54	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	53	suppressed
Metoprolol Succinate	Metoprolol Succinate	53	16
Tramadol Hcl	Tramadol Hcl	53	12
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Ibuprofen	Ibuprofen	51	15
Divalproex Sodium	Divalproex Sodium	49	suppressed
Risperidone	Risperidone	49	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	48	16
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Spironolactone	Spironolactone	45	suppressed
Chlorthalidone	Chlorthalidone	44	12
Diclofenac Sodium	Diclofenac Sodium	44	17
Baclofen	Baclofen	43	suppressed
Lovastatin	Lovastatin	40	suppressed
Lactulose	Lactulose	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	suppressed
Pentoxifylline	Pentoxifylline	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Divalproex Sodium Er	Divalproex Sodium	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	13
Azithromycin	Azithromycin	34	25
Olanzapine	Olanzapine	34	suppressed
Lithium Carbonate	Lithium Carbonate	33	suppressed
Propylthiouracil	Propylthiouracil	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	27	suppressed
Naproxen	Naproxen	26	suppressed
Vascepa	Icosapent Ethyl	25	suppressed
Enulose	Lactulose	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Multaq	Dronedarone Hcl	23	suppressed
Olanzapine Odt	Olanzapine	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Clotrimazole	Clotrimazole	21	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Cephalexin	Cephalexin	19	17
Procto-Med Hc	Hydrocortisone	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Temazepam	Temazepam	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Diazepam	Diazepam	15	suppressed
Digoxin	Digoxin	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Prednisone	Prednisone	15	suppressed
Sertraline Hcl	Sertraline Hcl	15	suppressed
Colchicine	Colchicine	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Acetazolamide Er	Acetazolamide	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Constulose	Lactulose	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Selenium Sulfide	Selenium Sulfide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Klor-Con 10	Potassium Chloride	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error